HomeNewsRespiratoryAsthma

  • Dupixent® (Dupilumab) approved by FDA for Asthma indication

    • October 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Spiriva Respimat gets UK license for young asthma patients

    • June 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • AstraZeneca’s Fasenra Fails in Phase III COPD Trial

    • May 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Novartis updates Launch Timeline for Advair Copy to 2019

    • April 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more